Phase Forward

Oracle to Acquire Phase Forward for $685M

Friday, April 16, 2010 02:37 PM

Business software giant Oracle, already a player in the eClinical space, plans to acquire market leader Phase Forward in a deal valued at approximately $685 million—or $17 per share in cash.

More... »


’09 Acquisitions Bring Phase Forward Revenues Up, Profits Down

Friday, February 5, 2010 10:19 AM

Phase Forward’s fourth quarter revenues jumped 22% but profits went down, the company reported Thursday night. Phase Forward’s share price was down 26.7% to $10.88 in early morning trading.

More... »


Phase Forward Appoints First Chief Privacy Officer

Thursday, December 24, 2009 07:40 AM

Phase Forward appointed long-time employee Michael Owings to the new role of chief privacy officer. Owings will oversee all privacy and data protection processes affecting Phase Forward’s customers and employees, and ensure compliance with all relevant regulations. He will also continue his duties as vice president, quality and regulatory compliance—a title he’s held since 2004.

More... »

Phase Forward Q3 Revenues Jump 24%, Earnings Down by Half

Friday, October 30, 2009 09:11 AM

Waltham, Mass-based Phase Forward, a provider of data management solutions for clinical trials and drug safety, reported third quarter revenues jumped 24% to $53.1 million, compared with the third quarter of 2008, but earnings were cut in half.

More... »

Phase Forward Provides Free Download for CDISC Adopters

Thursday, October 29, 2009 09:04 AM

Phase Forward, a provider of data management solutions for clinical trials and drug safety, released its DefineValidator tool, Release 1.0, as a free download for Clinical Data Interchange Standards Consortium (CDISC) adopters.

More... »

Phase Forward Receives SCDM Award

Friday, October 23, 2009 07:13 AM

The Society for Clinical Data Management has awarded its annual Data Driven Innovation Award to Phase Forward for developing a technology that increased external data loading rates 100-fold.

More... »

Phase Forward, Gedeon Richter in Multi-year Deal

Tuesday, October 13, 2009 06:42 AM

Phase Forward, a provider of data management solutions for clinical trials and drug safety, signed a multi-year agreement with Gedeon Richter, one of Central-Eastern Europe’s leading pharmaceutical companies with more than 10,000 employees worldwide.

More... »

SGS Partnership Helps Phase Forward Advance Business Strategy

Monday, August 24, 2009 06:50 AM

Phase Forward’s recent multi-million-dollar agreement with Swiss contract research organization (CRO) SGS Life Science Services not only provides the stability of a long-term contract to Phase Forward but also helps the eClinical provider advance its core strategy.

More... »

Phase Forward to Acquire Maaguzi for $11M, Profits Down in Q2

Tuesday, July 28, 2009 03:09 PM

Within days of announcing the pending acquisition of Covance’s interactive voice and web response business, eClinical company Phase Forward announced Monday it has purchased technology company Maaguzi for $11 million cash.

More... »

Phase Forward Agrees to $10M Acquisition, Multi-Year Partnership with Covance

Wednesday, July 15, 2009 01:30 PM

Covance is selling its interactive voice and web response services (IVR/IWR) business to eClinical provider Phase Forward for $10 million cash, and the two companies have entered into a multi-year agreement making Phase Forward a preferred provider for the contract research organization (CRO).

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs